|Articles|September 1, 1998

September 1998
Volume 4
Issue 9

Determining Whether Managed Care Formularies Meet the Needs of Pediatric Patients

Author(s)Pamela S. Smith, RPh

Download PDF: Determining Whether Managed Care Formularies Meet the Needs of Pediatric Patients

Articles in this issue

about 28 years ago

Article

Influence of a Critical Path Management Tool in the Treatment of Acute Myocardial Infarction

about 28 years ago

Article

Infectious Diseases and Anemia in a Sample of Out-of-Treatment Drug Users

about 28 years ago

Article

Assessing the Economic Value of Antihypertensive Medications

about 28 years ago

Article

The Rationale for Skin Cancer Screening and Prevention

about 28 years ago

Article

Effects of an Asthma Management Program on the Asthmatic Member: Patient-Centered Results of a 2-Year Study in a Managed Care Organization

about 28 years ago

Article

Evaluating and Improving the Delivery of Heart Care: The University of Michigan Experience

about 28 years ago

Article

A Case for Large-Core Biopsy Procedures in the Diagnosis of Breast Cancer

about 28 years ago

Article

Mental Disorders in the Primary Care Sector: A Potential Role for Managed Care

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Determining Whether Managed Care Formularies Meet the Needs of Pediatric Patients

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

60% of US Women Face Barriers to Postpartum, Mental Health Care

Cross-Trial Vitiligo Data: What Payers Can and Can't Compare

Amid SOHO Data, Reviewers of BTK Inhibitors in MCL Call for Trials